References
Lakhal K, Hivert A, Alexandre P-L, Fresco M, Robert-Edan V, Rodie-Talbere P-A, et al. Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021. https://doi.org/10.1007/s12028-021-01331-z.
Mahajan C, Shukla R, Kapoor I, Prabhakar H. Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage. Neurocrit Care (in press)
Velly LJ, Bilotta F, Fabregas N, Soehle M, Bruder NJ, Nathanson MH. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice. Eur J Anaesthesiol. 2015;32:168–76.
Mastantuono J-M, Combescure C, Elia N, Tramèr MR, Lysakowski C. Transcranial Doppler in the diagnosis of cerebral vasospasm: an updated meta-analysis. Crit Care Med. 2018;46(10):1665–72.
Diringer MN, Bleck TP, Claude Hemphill J, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40.
Funding
No funding was required for this study.
Author information
Authors and Affiliations
Contributions
Authorship requirements have been met, and the final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflict of interest
Karim Lakhal has no conflict of interest in connection with the work submitted. In addition, KL received, during the past 3 years, congress registration fees from Sanofi Aventis (once in 2018) and travel fees from MSD France (once in 2017), Gilead Sciences (once in 2017), Pfizer (three times, in 2019, 2020, and 2021), and Advanz Pharma (twice in 2020 and once in 2021). Vincent Robert-Edan has no conflict of interest in connection with the work submitted. In addition, VRE received, during the past 3 years, travel fees from Pfizer (once in 2020). None of the other authors have any financial or nonfinancial competing interests in connection with this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a response to a letter to the editor available at https://link.springer.com/article/10.1007/s12028-021-01392-0.
Rights and permissions
About this article
Cite this article
Lakhal, K., Robert-Edan, V., Rodie-Talbere, PA. et al. Intravenous Milrinone for Cerebral Vasospasm: Here Comes the Sun?. Neurocrit Care 36, 329–330 (2022). https://doi.org/10.1007/s12028-021-01392-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-021-01392-0